Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8366945 | 0.84 | — | — | |
| SCHEMBL9510919 | 0.83 | ALDH1A1 (0.35) | CYP2D6ALDH1A1 | |
| SCHEMBL16286962 | 0.79 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL2402939 | 0.77 | — | — | |
| SCHEMBL23257074 | 0.75 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL5932813 | 0.73 | — | — | |
| SCHEMBL2409442 | 0.73 | TSHR (0.37) | TSHRTDP1 | |
| SCHEMBL18769387 | 0.73 | — | — | |
| SCHEMBL21690219 | 0.71 | TSHR (0.33) | TSHR | |
| SCHEMBL23425128 | 0.69 | CYP2D6 (0.32) | CYP2D6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240358707-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | PHARMACYCLICS LLC (US) | 2024-10-31 | — | — | US | disclosed |
| US-20240317756-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | PHARMACYCLICS LLC (US) | 2024-09-26 | — | — | US | disclosed |
| US-20220213106-A1 | Inhibitors of Bruton's Tyrosine Kinase | PHARMACYCLICS LLC (US) | 2022-07-07 | — | — | US | disclosed |
| US-20220008424-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | PHARMACYCLICS LLC (US) | 2022-01-13 | — | — | US | disclosed |
| US-20200289515-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS | PHARMACYCLICS, INC. | 2020-09-17 | — | — | US | disclosed |
| US-20200276199-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS | PHARMACYCLICS LLC | 2020-09-03 | — | — | US | disclosed |
| US-20200108072-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | PHARMACYCLICS, INC. | 2020-04-09 | — | — | US | disclosed |
| US-20200055859-A1 | INHIBITORS OF BRUTONS TYROSINE KINASE | PHARMACYCLICS LLC (US) | 2020-02-20 | — | — | US | disclosed |
| US-20180193345-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS | PHARMACYCLICS LLC | 2018-07-12 | — | — | US | disclosed |
| EP-3311818-A2 | INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS | Pharmacyclics, LLC (US) | 2018-04-25 | — | — | EP | disclosed |
| US-6017496-A | ELECTROMAGNETICALLY TAGGED BY PROGRAMMING THE MEMORY WITH DATA CORRESPONDING TO IDENTIFYING INFORMATION OR CAN BE TAGGED BY IMPRINTING THE MATRIX WITH IDENTIFYING INFORMATION; DATA STORAGE; SLEEVE ATTACHED TO A CONTAINER | IRORI (US) | 2000-01-25 | — | — | US | disclosed |
| WO-1999065870-A2 | SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1999-12-23 | — | — | WO | disclosed |
| US-5961923-A | THE MATRIX MATERIALS ARE THOSE THAT ARE USED IN AS SUPPORTS IN SOLID PHASE CHEMICAL AND BIOCHEMICAL SYNTHESES, IMMUNOASSAYS AND HYBRIDIZATION REACTIONS. | IRORI (US) | 1999-10-05 | — | — | US | disclosed |
| US-5874214-A | USEFUL FOR IDENTIFICATION, TRACKING AND CATEGORIZATION OF COMPONENTS OF COMPLEX MIXTURES OF DIVERSE MOLECULES; DRUG DELIVERY | IRORI (US) | 1999-02-23 | — | — | US | disclosed |
| WO-1997049653-A9 | SOLID PHASE TYRPHOSTIN LIBRARY LINKED TO MATRICES WITH MEMORIES | — | 1998-04-16 | — | — | WO | disclosed |
| WO-1997012680-A9 | MATRICES WITH MEMORIES, SENSORS WITH MEMORIES AND USES THEREOF | — | 1998-02-26 | — | — | WO | disclosed |
| EP-0822861-A1 | REMOTELY PROGRAMMABLE MATRICES WITH MEMORIES AND USES THEREOF | Irori (US) | 1998-02-11 | — | — | EP | disclosed |
| WO-1997049653-A2 | SOLID PHASE TYRPHOSTIN LIBRARY LINKED TO MATRICES WITH MEMORIES | IRORI (US) | 1997-12-31 | — | — | WO | disclosed |
| WO-1996036436-A1 | REMOTELY PROGRAMMABLE MATRICES WITH MEMORIES AND USES THEREOF | IRORI (US) | 1996-11-21 | — | — | WO | disclosed |
| US-5189042-A | Treating autoimmune diseases, preventing transplant rejection | MERCK & CO. INC. (US) | 1993-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200108072-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | BTK, LCK, LYN | CYP2D6 2442/4885TSHR 3088/4885TDP1 325/4885 |
| US-20220213106-A1 | Inhibitors of Bruton's Tyrosine Kinase | ABL1, BTK, ABL2 | CYP2D6 4195/4885TSHR 3200/4885TDP1 284/4885 |
| US-20220008424-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | BTK, LCK, LYN | CYP2D6 2442/4885TSHR 3088/4885TDP1 325/4885 |
| US-20180193345-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS | BTK, ABL1, LYN | CYP2D6 4330/4885TSHR 2102/4885TDP1 348/4885 |
| US-20240358707-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | BTK, LCK, LYN | CYP2D6 2442/4885TSHR 3088/4885TDP1 325/4885 |
| US-20200289515-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS | BTK, ABL1, LYN | CYP2D6 4330/4885TSHR 2102/4885TDP1 348/4885 |
| US-20240317756-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | ABL1, BTK, ABL2 | CYP2D6 4195/4885TSHR 3200/4885TDP1 284/4885 |
| US-20200055859-A1 | INHIBITORS OF BRUTONS TYROSINE KINASE | ABL1, BTK, ABL2 | CYP2D6 4241/4885TSHR 2734/4885TDP1 365/4885 |
| US-20200276199-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS | BTK, ABL1, LYN | CYP2D6 4330/4885TSHR 2102/4885TDP1 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.